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Abstract
Objective—Program implementers have argued that the increasing availability of anti-retroviral 
therapy (ART) will reduce the stigma of HIV. We analyzed data from Uganda to assess how HIV-
related stigma has changed during a period of ART expansion.
Design—Serial cross-sectional surveys.
Methods—We analyzed data from the Uganda AIDS Rural Treatment Outcomes (UARTO) 
study during 2007-2012 to estimate trends in internalized stigma among people living with HIV 
(PLHIV) at the time of treatment initiation. We analyzed data from the Uganda Demographic and 
Health Surveys (DHS) from 2006 and 2011 to estimate trends in stigmatizing attitudes and 
anticipated stigma in the general population. We fitted regression models adjusted for socio-
demographic characteristics, with year of data collection as the primary explanatory variable.
Results—We estimated an upward trend in internalized stigma among PLHIV presenting for 
treatment initiation (adjusted b=0.18; 95% CI, 0.06 to 0.30). In the general population, the odds of 
reporting anticipated stigma were greater in 2011 compared to 2006 (adjusted OR=1.80; 95% CI, 
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1.51 to 2.13), despite an apparent decline in stigmatizing attitudes (adjusted OR=0.62; 95% CI, 
0.52 to 0.74).
Conclusions—Internalized stigma has increased over time among PLHIV in the setting of 
worsening anticipated stigma in the general population. Further study is needed to better 
understand the reasons for increasing HIV-related stigma in Uganda and its impact on HIV 
prevention efforts.
Keywords
Stigma; trends; incidence; HIV; Uganda
Introduction
In low- and middle-income countries (LMICs), HIV-related stigma has been associated with 
reduced uptake of voluntary counseling and testing[1,2] and increased sexual risk-taking 
behavior[3] in the general population. Among people living with HIV (PLHIV), stigma has 
been associated with emotional distress[4,5], decreased adherence to anti-retroviral therapy 
(ART)[6,7], and reduced likelihood of HIV status disclosure[8,9]. One argument for 
increasing access to ART was that doing so would reduce stigma[10,11] through 
improvements in physical health and HIV-related symptom burden[12] leading to economic 
rehabilitation and social reintegration[13,14]. However, the extent to which levels of HIV-
related stigma have actually changed in LMICs during the past decade of treatment scale-up 
is unclear. A better understanding of temporal trends in stigma in LMICs would help 
elucidate the impact of ART availability on stigma and the potential need for interventions 
beyond ART to reduce stigma.
We attempted to address this question using serial cross-sections of data from two sources: 
the Uganda AIDS Rural Treatment Outcomes (UARTO) study, a longitudinal cohort study 
of PLHIV in southwestern Uganda who initiate ART upon enrollment; and the Uganda 
Demographic and Health Surveys (DHS)[15,16], which were nationally representative, 
population-based surveys conducted in Uganda in 2006 and 2011. Analyzing data from 
UARTO allowed us to examine temporal trends in internalized stigma among PLHIV newly 
initiating ART[17,18], while the DHS allowed us to examine trends in stigmatizing attitudes 
(i.e., expressions of social distance) [18,19] and fears about disclosure (i.e., anticipated 
stigma)[17,20] in the general population. We had two specific aims: (a) to estimate temporal 
trends in internalized stigma from 2007 to 2012 among PLHIV presenting for ART 
initiation; and (b) to understand temporal trends in stigmatizing attitudes and fears about 
disclosure among persons in the general community.
Methods
Uganda AIDS Rural Treatment Outcomes (UARTO) study
The UARTO study enrolls participants from the Mbarara Regional Referral Hospital 
Immune Suppression Syndrome Clinic, Mbarara, Uganda, an HIV clinic serving the 
Mbarara district (population 1.1 million, 92% in rural areas) and adjacent districts[21]. 
Participants were eligible for enrollment in the UARTO cohort if they were treatment-naïve 
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and newly initiating ART, were at least 18 years of age, and lived within 60 kilometers of 
the clinic. 49% of patients who were approached for study participation agreed to be 
enrolled. At the pre-treatment baseline visit, participants underwent blood draws and 
structured interviews conducted in the local language, Runyankole. The scale for measuring 
internalized stigma (described in more detail below) was added to the study questionnaire 
beginning in August 2007. Therefore, only participants whose baseline visits occurred 
between August 2007 and December 2012 were included in this analysis.
Study staff obtained signed, or in case of illiteracy, thumbprint-indicated informed consent 
from all participants. Ethical approval for study procedures was obtained from ethical 
review committees at the University of California at San Francisco, San Francisco, 
California, USA, Partners Healthcare, Boston, Massachusetts, USA, and the Mbarara 
University of Science and Technology, Mbarara, Uganda. Consistent with national 
guidelines, we received clearance for the study from the Uganda National Council for 
Science and Technology, Kampala, Uganda, and from the Research Secretariat in the Office 
of the President, Kampala, Uganda.
The primary outcome of interest was internalized stigma, as measured with the six-item 
Internalized AIDS-Related Stigma Scale (IARSS)[22]. The IARSS has demonstrated a 
coherent internal structure and good reliability and construct validity among PLHIV in 
Uganda[9,23]. Two scale items relate to concerns about disclosure (felt stigma)[24] and four 
items relate to feelings of shame and/or self-hatred[25] (see Table 1). Among study 
participants at enrollment, the estimated scale reliability coefficient for the IARSS was 0.89.
Explanatory variables of interest measured at ART initiation included physical health status, 
CD4+ T-lymphocyte cell count, body mass index (BMI), depression symptom severity, and 
socio-demographic variables. Physical health status was measured using the Medical 
Outcomes Study-HIV Health Survey (MOS-HIV) Physical Health Summary (PHS) 
score[26]. Depression symptom severity was measured as a continuous variable using the 
depression sub-scale of the Hopkins Symptom Checklist (HSCL-D)[27]. The scale was 
adapted for the Ugandan context[28,29], with the four somatic items deleted to avoid 
possible overlap between symptoms of depression and symptoms of HIV infection[30]. 
Among study participants at enrollment, the estimated scale reliability coefficient for the 
modified HSCL-D was 0.86.
Socio-demographic variables included age, gender, educational attainment, marital status, 
household asset wealth, employment status, and travel time to/from clinic. Household asset 
wealth was measured by applying principal components analysis to a series of 25 binary 
variables for household-owned assets and housing characteristics[31]. The first principal 
component was retained and used to define the wealth index and was entered into the 
regression models as a continuous variable, with higher values indicating greater asset 
wealth. Self-reported travel time to/from clinic was included as a proxy for rural residence.
Uganda Demographic and Health Surveys (DHS)
The Uganda DHS are nationally-representative, population-based surveys that were 
conducted in Uganda in 2006 and 2011. Each iteration of the DHS used a stratified two-
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stage cluster sampling design based on the sampling frame from the 2002 Population 
Census. By design, the majority of participants were women. Details of the sampling 
procedures are included in the full published reports[15,16]. We limited our analyses to 
participants in the southwest region of Uganda (the region from which the participants in the 
UARTO study were drawn).
The primary outcomes of interest from the DHS were fears about disclosure and 
stigmatizing attitudes. Fear of disclosure was assessed by the question “If a member of your 
family got infected with the AIDS virus, would you want it to remain a secret or not?” 
Positive responses to this question reflect anticipated stigma in the general population[20]--
similar to felt stigma that may be experienced by PLHIV[24]--or the expectation of rejection 
were one to test HIV positive and the test result revealed to others[17]. Stigmatizing 
attitudes were assessed by three questions: 1) “If a member of your family became sick with 
AIDS, would you be willing to care for her or him in your own household?”; 2) “ Would 
you buy fresh vegetables from a shopkeeper or vendor if you knew that this person had the 
AIDS virus?”; and 3) “In your opinion, if a female teacher has the AIDS virus but is not 
sick, should she be allowed to continue teaching in the school?” Positive responses to these 
questions reflect expressions of social distance[18], or an unwillingness to engage in certain 
forms of interaction with PLHIV (often motivated by instrumental concerns about casual 
transmission [19]). A binary composite variable was created from these three questions, 
equal to one if the participant expressed at least one stigmatizing attitude. As a sensitivity 
analysis, an ordinal composite variable was also created, with values ranging from zero 
(answering no to all three questions) to three (answering yes to all three questions).
Socio-demographic variables, including age, gender, educational attainment, marital status, 
household asset wealth[31], and employment status, were included in the analysis as 
potential confounders of the relationship between time and stigma. We also included a 
composite HIV knowledge variable equal to the number of correct responses to six questions 
about HIV prevention and transmission (Appendix 1).
Statistical Analysis
To summarize changes in internalized stigma at time of ART initiation among UARTO 
participants by year of cohort entry, we estimated mean stigma (IARSS) scores among 
participants with complete data on the variables of interest. To estimate changes in IARSS 
scores over time, we fitted a linear regression model with robust standard errors to the data 
with IARSS as the outcome variable and year of cohort entry as the explanatory variable. A 
statistically significant regression coefficient was considered evidence that stigma among 
PLHIV at ART initiation was changing over time. As an alternative parameterization, we 
fitted a linear regression model specifying time as a series of dummy variables for each 1-
year period, using a Wald-type F test to test the joint statistical significance of the time 
dummy variables. Estimates were adjusted for socio-demographic characteristics measured 
at ART initiation as described above. To determine whether temporal trends in clinical 
factors at presentation could explain observed stigma trends in the UARTO cohort, we 
sequentially added clinical explanatory variables (BMI, CD4 count, PHS, and HSCL-D) to 
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the regression model and then re-assessed the statistical significance of the regression 
coefficient for year of cohort entry.
To summarize changes in fears about disclosure and stigmatizing attitudes in the DHS 
sample (among respondents living in southwestern Uganda only), we merged the 2006 and 
2011 datasets into a single dataset with year of DHS as a variable. We used two-sample tests 
of proportions to compare fears about disclosure and stigmatizing attitudes between 2006 
and 2011. To adjust for changes in socio-demographic characteristics, we fitted logistic 
regression models to the data with year of DHS and socio-demographic variables as 
explanatory variables. Using these multivariable models, we then sought to identify whether 
changes in knowledge of HIV explained changes in stigma by adding the composite 
knowledge variable to the models and re-assessing the statistical significance of the year 
indicator.
All analyses were performed using SAS software (Version 9.3, SAS Institute, Cary, NC). 
Regression diagnostic procedures yielded no evidence of collinearity or overly-influential 
outliers in any of the models. Because our analyses of the DHS were limited to participants 
living in southwestern Uganda, we did not apply survey weights or clustering variables to 
obtain nationally representative estimates.
Results
Temporal trends in internalized stigma among UARTO participants
There were 229 women (70%) and 100 men (30%) in the sample for whom complete case 
data were available (see Appendix 2 for details). Due to a restructuring of study 
administration and interruption in salary support for study staff, recruitment was limited to 
ten participants in 2010. Baseline characteristics are described in Table 1.
Mean stigma scores by year of cohort entry are shown in Figure 1; in item-by-item analyses, 
statistically significant upward trends were observed for all items except for the item “I 
sometimes feel worthless because I am HIV positive” (b=0.02, p=0.06). In univariable 
analysis, a statistically significant positive association between year of entry and IARSS 
score was observed (b=0.17; 95% CI, 0.05-0.28). This suggests an 11.0% (0.17/1.54=0.11) 
increase per year, relative to the baseline value, in the mean internalized stigma score among 
newly enrolled participants at cohort entry. The alternative parameterization specifying time 
as a series of dummy variables was consistent with this finding, rejecting the null hypothesis 
that mean IARSS score at ART initiation was constant across time (F=3.77, p=0.003).
After multivariable adjustment for baseline socio-demographic characteristics, the adjusted 
regression coefficient for year of cohort entry remained statistically significant (b=0.18; 
95% CI, 0.06-0.30) (Table 2). The statistical significance remained unchanged with the 
addition of each of the clinical explanatory variables of interest (PHS, BMI, CD4 count, or 
HSCL-D) to the multivariable linear regression model, suggesting that changes over time in 
health status at ART initiation did not explain the observed trend towards increasing stigma.
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Temporal trends in stigmatizing attitudes and fears of disclosure in southwestern Uganda
Complete case data (see Appendix 2) on persons living in southwestern Uganda were 
available on 1,141 participants in the 2006 DHS and 1,106 participants in the 2011 DHS 
(Table 3). Comparing 2006 and 2011, statistically significant differences were found in 
stigmatizing attitudes and fears about disclosure. Respondents in 2011 were more likely to 
display an accepting attitude on all three indicators of stigmatizing attitudes (59% vs. 46%, 
χ2=38.2, p<0.001). However, respondents in 2011 were also more likely to endorse fears 
about disclosure (61% vs. 47%, χ2=43.4, p<0.001). Adjustment for socio-demographic 
variables and HIV knowledge yielded no substantive changes in these findings (Table 4).
Discussion
In this analysis of data from southwestern Uganda, we observed an increase over time in 
internalized stigma among PLHIV initiating ART. This increase was not explained by 
compositional changes in socio-demographic characteristics, health status, or psychosocial 
well-being at treatment initiation. During the same time period, we observed that a 
significantly higher percentage of people in the general population endorsed fears about 
disclosure despite an apparent increase in accepting attitudes towards PLHIV. Our findings 
suggest that the expansion of ART alone may be insufficient to reduce HIV-related stigma 
and that further targeted efforts to counter stigma are necessary, such as educational 
campaigns[32], changes to laws or policies that institutionalize stigma[7], and/or livelihood 
interventions[10].
Our analysis of the 2006 and 2011 DHS suggests that anticipated stigma has worsened in the 
community despite a decline in stigmatizing attitudes towards PLHIV. What could explain 
these divergent trends in the general population? Social desirability bias may offer one 
potential explanation[33]. Namely, the widely disseminated HIV prevention campaigns in 
Uganda[34,35] may have sensitized people to knowing how they ought to feel about PLHIV 
without actually changing how they actually feel about PLHIV. This could potentially 
explain why anticipated stigma increased (i.e., respondents expressed fear of disclosure in 
the event of a hypothetical case of HIV infection in their family) even while indicators of 
stigmatizing attitudes declined (i.e., because respondents increasingly understand that they 
should endorse accepting attitudes towards PLHIV). An alternative interpretation is that, 
while respondents may have actually changed their own attitudes towards PLHIV, they may 
have perceived that others in society have not. Thus, the trend towards increasing acceptance 
of PLHIV may reflect respondents' true feelings, but the belief that such attitudes remain 
prevalent in society may result in persistent fears of disclosure.
In turn, the persistence of fears about disclosure in the community could adversely affect 
PLHIV through two hypothesized social psychological mechanisms (explained by Link[18] 
in the context of mental illness stigma). First, during socialization, PLHIV may devalue 
themselves because they see themselves as belonging to a person group that most others in 
the general population view negatively. Second, PLHIV who are concerned about the 
stigmatizing attitudes held by others will engage in negative defenses such as covering and 
isolation. Either or both of these mechanisms could explain why internalized stigma among 
PLHIV increased over time.
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It remains unclear whether our findings reflect trends in other populations in sub-Saharan 
Africa. Program implementers from Partners in Health[11,36] as well as investigators in 
South Africa[37], Botswana[20], Uganda[10,12], and Malawi[38], have argued that the 
increasing availability of ART should be associated with reduced levels of stigma in the 
general population. This experience has not been observed universally. For example, 
Maughan-Brown[39] found an increase in several dimensions of stigma among the general 
population of South Africa in 2003-2006 despite ART expansion. This finding may be 
related to the idea that ART does little to counter persistent blaming attitudes and feelings of 
moral outrage in the community; indeed, ART may be perceived as allowing PLHIV to 
appear healthy enough to engage in promiscuous behaviors and spread HIV[39-41]. 
Niehaus[42], on the other hand, argued that any association with perceived deviance 
provides an insufficient explanation for persisting negative attitudes towards PLHIV. Lack 
of trust among the general population in the efficacy and sustainability of ART may also 
mitigate the positive effects of ART expansion on stigma[43,44]. Finally, Maughan-Brown 
studied only the earliest period of treatment expansion. With additional observation periods, 
it is possible that the trends observed in his study would have changed.
We contend that there is reason to believe that our findings may be unique to Uganda and 
that the persistence of stigma may be related to the country's status as the only country in 
sub-Saharan Africa to have experienced an increasing incidence of HIV in the past 
decade[45,46]. Formerly hailed as an HIV/AIDS “success story”[47], Uganda's 
achievements in controlling the spread of HIV have stalled as the number of new infections 
per year in Uganda has increased from approximately 69,000 in 2001 to 120,000 in 
2012[45]. There is growing concern that the recent drafting of anti-homosexuality 
legislation may have increased HIV-related stigma and discouraged people from being 
tested and treated[48-50]. Moreover, many observers fear that HIV-related stigma will be 
further exacerbated by recently-passed legislation that criminalizes “willful” HIV 
transmission and permits medical providers to disclose a patient's HIV status to 
others[49,51]. Given the urgent need to reduce new HIV infections and HIV-related deaths 
in Uganda, further investigation into the relationship between stigma and persistently high 
HIV incidence as well as interventions to reduce HIV-related stigma may be warranted.
There are several limitations to our study. First, our data are derived from a single region of 
Uganda. Regional heterogeneity in stigmatizing attitudes has been described[52]. 
Furthermore, as discussed above, it is uncertain whether our findings represent a trend 
unique to Uganda or reflect trends that exist in other LMICs. The IARSS scores in the 
UARTO cohort (mean=1.5) appeared to be lower compared to those obtained in surveys 
conducted in South Africa (mean=3.0) and Swaziland (mean=2.2)[22]. These differences 
may be due to the fact that those data were collected in hyperendemic settings during an 
earlier time period compared to the UARTO cohort. Second, our measures of anticipated 
stigma and social distance, which are also used as core indicators for monitoring the HIV 
epidemic by the Joint United Nations Programme on HIV/AIDS[53], describe hypothetical 
situations that survey respondents could have misunderstood without being provided with 
further information. Although this limitation is well-known[33,54], it would only lead to 
biased estimates of temporal trends in stigma if respondents' comprehension of these 
specific questions were also systematically changing over time. Third, the study sample of 
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PLHIV consisted primarily of women. However, this is typical of other HIV cohorts in sub-
Saharan Africa. For example, in the meta-analysis of more than 200,000 PLHIV by Druyts 
et al.[55], nearly two-thirds of participants were women. Similar findings were reported by 
Muula et al.[56] Fourth, we were unable to evaluate the role of health care providers' 
attitudes toward PLHIV as a contributing factor to the increase in internalized stigma among 
PLHIV; although participants in the UARTO cohort were ART-naïve, about half of them 
had had previous contact with HIV providers. Because disrespect of PLHIV among 
providers in sub-Saharan Africa has been shown to be a potentially important cause of 
disengagement from HIV care[57], further study on trends in health care providers' attitudes 
would be helpful in understanding the reasons for increasing internalized stigma among 
PLHIV.
In conclusion, in this study of rural southwestern Uganda, we found evidence for a temporal 
trend of increasing stigma among PLHIV presenting for ART initiation as well as persisting 
anticipated stigma among the general population. Despite the growing availability of ART, 
which has allowed increasing numbers of PLHIV to restore physical health and rehabilitate 
economically and socially, these forms of stigma remain highly prevalent and may have 
worsened. Our findings underscore the need to better understand reasons for persistent 
stigma in the era of ART expansion and more effective methods to reduce stigma among 
PLHIV and in the general population.
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Figure 1. Mean IARSS scores by year of entry
Bars represent standard errors.
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Table 1
Characteristics of participants in UARTO cohort at time of enrollment (n=329)
Characteristic Mean (SD) or no. (%)
Year of cohort entry
 2007 51 (16%)
 2008 83 (25%)
 2009 37 (11%)
 2010 10 (3%)
 2011 78 (24%)
 2012 70 (21%)
Female 229 (70%)
Age, years 34 (10)
Achieved more than primary education 80 (24%)
Married 182 (55%)
Household asset index -0.01 (2.0)
Employed 243 (74%)
Travel time to/from clinic, minutes 52 (41)
Body mass index 22 (4)
CD4 cell count 221 (152)
MOS-HIV physical health summary score 53 (11)
HSCL-D score 1.50 (0.52)
Probable depression (HSCL-D>1.75) 81 (25%)
IARSS score 1.54 (2.05)
 Being HIV positive makes me feel dirty 58 (18%)
 I feel guilty that I am HIV positive 88 (27%)
 I am ashamed that I am HIV positive 76 (23%)
 I sometimes feel worthless because I am HIV positive 45 (14%)
 I hide my HIV status from others 123 (37%)
 It is difficult to tell people about my HIV infection 116 (35%)
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Table 2
Linear regression estimates for the association between year of cohort entry and IARSS 
score, with covariates
Variable Adjusted coefficient 95% CI
Year of cohort entry 0.177 (0.056, 0.298)
Female 0.203 (-0.332, 0.737)
Age, per 10 years -0.339 (-0.576, -0.102)
Achieved secondary education 0.323 (-0.222, 0.868)
Unmarried 0.244 (-0.234, 0.722)
Asset index 0.031 (-0.090, 0.151)
Unemployed 0.032 (-0.485, 0.549)
Time to clinic, per minute 0.006 (0.0002, 0.011)
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Table 3
Characteristics of participants in 2006 and 2011 DHS (southwest region, n=2247)
Characteristic Mean (SD) or no. (%)
Year of DHS
 2006 1,141 (51%)
 2011 1,106 (49%)
Sociodemographic variables
Female 1,865 (78%)
Age, years 29 (10)
Achieved more than primary education 468 (21%)
Married 1,355 (60%)
Wealth index 0.03 (0.75)
Employed 1,835 (82%)
Stigma and knowledge variables
Expresses accepting attitude on all 3 stigmatizing attitudes indicators 1,178 (52%)
Would want it kept secret if family member had HIV 1,203 (54%)
No. of correct answers to 6 HIV knowledge questions 4.8 (1.1)
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